Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cathepsin B, Cathepsin K, Cathepsin L, and Cathepsin S are lysosomal cysteine proteases involved in the degradation of intracellular and extracellular proteins. They play essential roles in protein turnover, antigen presentation, apoptosis, and tissue remodeling. Specific members have unique physiological and pathological implications; for example, Cathepsin K is crucial for bone resorption by osteoclasts, Cathepsin S mediates antigen presentation in immune cells, and Cathepsins B and L regulate apoptosis and cancer cell invasion. Therapeutically, they are primary molecular targets for drugs intended to treat cancer, osteoporosis, autoimmune diseases, and fibrosis, but selectivity and safety remain clinical challenges.
Cysteine protease inhibition (block active site, reduce protein breakdown); Modulation of immune cell function and antigen presentation; Reduction of extracellular matrix degradation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cathepsin B, Cathepsin K, Cathepsin L, and Cathepsin S (CTS).